128 related articles for article (PubMed ID: 24708452)
1. Olanzapine for intractable nausea and vomiting in palliative care patients not receiving chemotherapy.
Atkinson SR
J Palliat Med; 2014 May; 17(5):503-4. PubMed ID: 24708452
[No Abstract] [Full Text] [Related]
2. A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients.
Fonte C; Fatigoni S; Roila F
Crit Rev Oncol Hematol; 2015 Aug; 95(2):214-21. PubMed ID: 25779971
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine in the Management of Difficult to Control Nausea and Vomiting in a Palliative Care Population: A Case Series.
MacKintosh D
J Palliat Med; 2016 Jan; 19(1):87-90. PubMed ID: 26398872
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine in the treatment of refractory nausea and vomiting: a case report and review of the literature.
Langley-DeGroot M; Ma JD; Hirst J; Roeland EJ
J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):148-52. PubMed ID: 26095486
[TBL] [Abstract][Full Text] [Related]
5. Use of olanzapine for the relief of nausea and vomiting in patients with advanced cancer: a multicenter survey in Japan.
Kaneishi K; Nishimura K; Sakurai N; Imai K; Matsuo N; Takahashi N; Okamoto K; Suga A; Sano H; Maeda I; Nishina H; Yamaguchi T; Morita T; Iwase S
Support Care Cancer; 2016 Jun; 24(6):2393-5. PubMed ID: 26838020
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine for the relief of nausea in patients with advanced cancer and incomplete bowel obstruction.
Kaneishi K; Kawabata M; Morita T
J Pain Symptom Manage; 2012 Oct; 44(4):604-7. PubMed ID: 22771132
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine for nausea and vomiting.
Licup N
Am J Hosp Palliat Care; 2010 Sep; 27(6):432-4. PubMed ID: 20508243
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine for intractable nausea in palliative care patients.
Jackson WC; Tavernier L
J Palliat Med; 2003 Apr; 6(2):251-5. PubMed ID: 12854942
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : a review].
Benze G; Alt-Epping B; Geyer A; Nauck F
Schmerz; 2012 Sep; 26(5):500-14. PubMed ID: 22968365
[TBL] [Abstract][Full Text] [Related]
10. The Benefits of Olanzapine in Palliating Symptoms.
Davis MP; Sanger GJ
Curr Treat Options Oncol; 2020 Nov; 22(1):5. PubMed ID: 33244634
[TBL] [Abstract][Full Text] [Related]
11. Re: Olanzapine-induced delirium.
Prommer E
J Pain Symptom Manage; 2005 Feb; 29(2):119-20. PubMed ID: 15733804
[No Abstract] [Full Text] [Related]
12. Olanzapine for Nausea, Delirium, Anxiety, Insomnia, and Cachexia #315.
Felton M; Weinberg R; Pruskowski J
J Palliat Med; 2016 Nov; 19(11):1224-1225. PubMed ID: 27267313
[No Abstract] [Full Text] [Related]
13. Management of nausea and vomiting in palliative care.
Neoh K; Adkinson L; Montgomery V; Hurlow A
Br J Hosp Med (Lond); 2014 Jul; 75(7):391-2, 394-6. PubMed ID: 25040518
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine-induced delirium in a terminally ill cancer patient.
Morita T; Tei Y; Shishido H; Inoue S
J Pain Symptom Manage; 2004 Aug; 28(2):102-3. PubMed ID: 15276190
[No Abstract] [Full Text] [Related]
15. [Medical treatment of chemotherapy-induced nausea and vomiting].
Herrstedt J
Ugeskr Laeger; 2007 Feb; 169(9):799-805. PubMed ID: 17355844
[TBL] [Abstract][Full Text] [Related]
16. Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.
Srivastava M; Brito-Dellan N; Davis MP; Leach M; Lagman R
J Pain Symptom Manage; 2003 Jun; 25(6):578-82. PubMed ID: 12782438
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Olanzapine for Symptom Relief in Cancer Patients.
Nakagawa N; Suzuki M
J Pain Palliat Care Pharmacother; 2022 Dec; 36(4):216-222. PubMed ID: 36250742
[TBL] [Abstract][Full Text] [Related]
18. Symptom control, treatment-induced nausea prophylaxis, and palliative radiation therapy.
Simone CB
Ann Palliat Med; 2018 Apr; 7(2):E2-E4. PubMed ID: 29764180
[No Abstract] [Full Text] [Related]
19. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving highly or moderately emetogenic chemotherapy: a randomized, double-blind, placebo-controlled study.
Mizukami N; Yamauchi M; Koike K; Watanabe A; Ichihara K; Masumori N; Yamakage M
J Pain Symptom Manage; 2014 Mar; 47(3):542-50. PubMed ID: 23856100
[TBL] [Abstract][Full Text] [Related]
20. Palliative care. Nausea and vomiting.
Kinghorn S
Nurs Times; 1997 Aug 13-19; 93(33):57-60. PubMed ID: 9335885
[No Abstract] [Full Text] [Related]
[Next] [New Search]